Patents by Inventor James Rottman

James Rottman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 11913000
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: February 27, 2024
    Assignee: IVERIC bio, Inc.
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS
    Publication number: 20210332361
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: March 12, 2021
    Publication date: October 28, 2021
    Applicant: ARCHEMIX LLC
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 10947544
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: February 28, 2019
    Date of Patent: March 16, 2021
    Assignee: Archemix LLC
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS
    Publication number: 20190185858
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: February 28, 2019
    Publication date: June 20, 2019
    Applicant: ARCHEMIX LLC
    Inventors: CLAUDE BENEDICT, DAVID EPSTEIN, CHARLES WILSON, DILARA MCCAULEY, JEFFREY KURZ, MARKUS KURZ, THOMAS GREENE MCCAULEY, JAMES ROTTMAN
  • APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS
    Publication number: 20180030446
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: March 2, 2017
    Publication date: February 1, 2018
    Applicant: ARCHEMIX LLC
    Inventors: Claude BENEDICT, David EPSTEIN, Charles WILSON, Dilara MCCAULEY, Jeffrey KURZ, Markus KURZ, Thomas Greene MCCAULEY, James ROTTMAN
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 9617546
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: April 11, 2017
    Assignee: Archemix LLC
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • Aptamer Therapeutics Useful in the Treatment of Complement-Related Disorders
    Publication number: 20150159158
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: December 17, 2014
    Publication date: June 11, 2015
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 8946184
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: March 4, 2013
    Date of Patent: February 3, 2015
    Assignee: Archemix LLC
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS
    Publication number: 20130237589
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: March 4, 2013
    Publication date: September 12, 2013
    Applicant: ARCHEMIX LLC
    Inventors: Claude BENEDICT, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 8436164
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: June 18, 2012
    Date of Patent: May 7, 2013
    Assignee: Archemix LLC
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • APTAMER THERAPEUTICS USEFUL IN THE TREATMENT OF COMPLEMENT-RELATED DISORDERS
    Publication number: 20120322860
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: June 18, 2012
    Publication date: December 20, 2012
    Applicant: ARCHEMIX LLC
    Inventors: CLAUDE BENEDICT, DAVID EPSTEIN, CHARLES WILSON, DILARA MCCAULEY, JEFFREY KURZ, MARKUS KURZ, THOMAS GREENE MCCAULEY, JAMES ROTTMAN
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 8236773
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: February 14, 2006
    Date of Patent: August 7, 2012
    Assignee: Archemix LLC
    Inventors: Claude Benedict, David Epstein, Charles Wilson, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman
  • FERROPORTIN ANTIBODIES AND METHODS OF USE
    Publication number: 20110274691
    Abstract: Compositions for treating disorders of iron homeostasis are provided. More particularly, anti-ferroportin antibodies, compositions containing such antibodies, corresponding nucleic acids, vectors and host cells, and methods of making such antibodies are provided.
    Type: Application
    Filed: January 23, 2009
    Publication date: November 10, 2011
    Inventors: Tara Arvedson, James Rottman, Barbra Sasu, Gregory Dyas
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 7803931
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: February 14, 2005
    Date of Patent: September 28, 2010
    Assignee: Archemix Corp.
    Inventors: Claude Benedict, John Diener, David Epstein, Dilara Grate, Sara Chesworth Keene, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman, Kristin Thompson, Charles Wilson, Anna J. Zoltoski
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 7579456
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: February 14, 2006
    Date of Patent: August 25, 2009
    Assignee: Archemix Corp.
    Inventors: Claude Benedict, David Epstein, Dilârâ McCauley, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman, Charles Wilson
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Patent number: 7538211
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: May 26, 2009
    Assignee: Archemix Corp.
    Inventors: Claude Benedict, John Diener, David Epstein, Dilara Grate, Sara Chesworth Keene, Jeffrey Kurz, Markus Kurz, Thomas Greene McCauley, James Rottman, Kristin Thompson, Charles Wilson, Anna J. Zoltoski
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Publication number: 20070048248
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: February 14, 2006
    Publication date: March 1, 2007
    Inventors: Claude Benedict, David Epstein, Dilara McCauley, Jeffrey Kurz, Markus Kurz, Thomas McCauley, James Rottman, Charles Wilson
  • TECHNOLOGY PORTFOLIO HEALTH ASSESSMENT SYSTEM AND METHOD
    Publication number: 20060224479
    Abstract: A system and method for producing infrastructure health assessments enabling enterprises to monitor the health of individual technology portfolios and plan accordingly is disclosed. The tool uses two primary assessments to determine: 1) an infrastructure score based the general health of asset components; and 2) adaptability score based on asset components ability to interact with other elements within the asset. To generate the assessment scores, the tool accepts inventory input specific to a portfolio's assets and components. A user interacting with the tool provides classification information relating to each asset and component. The tool then calculates health assessment scores for both individual portfolio assets and for the portfolio as a whole.
    Type: Application
    Filed: March 29, 2005
    Publication date: October 5, 2006
    Applicant: AMERICAN EXPRESS TRAVEL RELATED SERVICES COMPANY, INC.
    Inventors: Fred Bishop, Sherry Easterwood, Pradeep George, Robert Gilmore, James Mathews, Lawrence Mitsch, James Rottman, James Thornton
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Publication number: 20060105980
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: December 22, 2005
    Publication date: May 18, 2006
    Inventors: Claude Benedict, John Diener, David Epstein, Dilara Grate, Sara Keene, Jeffrey Kurz, Markus Kurz, Thomas McCauley, James Rottman, Kristin Thompson, Charles Wilson, Anna Zoltoski
  • Aptamer therapeutics useful in the treatment of complement-related disorders
    Publication number: 20060018871
    Abstract: The invention provides nucleic acid therapeutics and methods for using these nucleic acid therapeutics in the treatment of complement-related disorders.
    Type: Application
    Filed: February 14, 2005
    Publication date: January 26, 2006
    Inventors: Claude Benedict, John Diener, David Epstein, Dilara Grate, Sara Keene, Jeffrey Kurz, Markus Kurz, Thomas McCauley, James Rottman, Kristin Thompson, Charles Wilson, Anna Zoltoski